retatrutide vs slu pp 332 SLU-PP-332 + Stack: Eat Less, Burn More (2026) SLU-PP-332, CAS 303760-60-3, poudre de

When food already feels less appealing, an intensely sweet or chalky shake is one of the first things people put down

Research consistently shows that people who prioritize protein on GLP-1 medications lose more fat and less muscle than those who do not

Mol Metab 20 , 5162 (2019)

Such comprehensive care will support treatment benefits beyond body weight alone and will make clinicians more effective stewards of GLP-1s and, ultimately, of patients overall health

Pharmacologically mediated, marked initial maternal body weight loss and reductions in body weight gain and food consumption coincided with the occurrence of sporadic abnormalities (vertebra, sternebra, ribs) at 0.075 mg/kg twice weekly (9X human exposure)

The results in humans, however, were modest enough that it has not advanced to Phase 3 approval for any fat loss indication